
Castle Biosciences CSTL
€ 19.95
0.0%
Quartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Castle Biosciences Finanzkreislauf 2011-2026 | CSTL
Finanzkreislauf Jährlich Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.9 | 38.8 | 47 | 53.6 | 78.8 | 71.7 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 78.8 | 38.8 | 56 |
Finanzkreislauf Vierteljährlich Castle Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.5 | 40.8 | 54.6 | - | 46 | 36.5 | 37.5 | - | 41.9 | 27.1 | 27.8 | - | 46.3 | 50.5 | 51.8 | - | 74.3 | 75.4 | 58 | 67.3 | 80.9 | 96.6 | 62.1 | 75.8 | 56.9 | 95.7 | 106 | 96.5 | 259 | 119 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 259 | 27.1 | 70 |
Finanzkreislauf anderer Aktien in der Diagnostik & Forschung
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 17.93 | 11.3 % | $ 193 M | ||
|
Agilent Technologies
A
|
111 | $ 117.5 | - | $ 35.7 B | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 16.83 | - | $ 897 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 501.23 | - | $ 14.5 B | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 4.59 | - | $ 425 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.45 | - | $ 1.93 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 6.72 | - | $ 280 M | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 52.64 | - | $ 2.68 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
17.3 | $ 1.39 | - | $ 91.7 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 178.34 | 0.01 % | $ 8.84 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 514.23 | - | $ 194 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.7 | - | $ 61.9 M | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
77.5 | $ 195.87 | - | $ 140 B | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 50.38 | - | $ 3.01 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
142 | $ 126.96 | - | $ 20.2 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.3 | - | $ 463 M | ||
|
Waters Corporation
WAT
|
731 | $ 324.68 | - | $ 19.3 B | ||
|
Guardant Health
GH
|
79.6 | $ 82.21 | - | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.85 | - | $ 92.5 K | ||
|
Biomerica
BMRA
|
172 | $ 2.08 | - | $ 4.78 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.55 | - | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 110.37 | - | $ 9.1 B | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 264.18 | - | $ 22 B | ||
|
Exagen
XGN
|
-3.23 | $ 2.97 | - | $ 64 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.0 | - | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 9.14 | - | $ 1.98 B | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 81.67 | - | $ 5.51 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |